Actavis ready to buy Botox-maker Allergan in $66 billion
NEW YORK: Actavis has agreed to buy Botox-maker Allergan AGN 1.24% in $66 billion in a cash and stock deal ...
Tag: AGN 1.24%
NEW YORK: Actavis has agreed to buy Botox-maker Allergan AGN 1.24% in $66 billion in a cash and stock deal ...
